Suppr超能文献

羟基酪醇衍生化合物:用于癌症预防和治疗的新型药理活性剂的研发基础。

Hydroxytyrosol-Derived Compounds: A Basis for the Creation of New Pharmacological Agents for Cancer Prevention and Therapy.

作者信息

Bernini Roberta, Gilardini Montani Maria Saveria, Merendino Nicolò, Romani Annalisa, Velotti Francesca

机构信息

Department of Agriculture, Nature, Forests and Energy (DAFNE), Tuscia University , Via S. Camillo De Lellis, 01100 Viterbo, Italy.

Department of Experimental Medicine, Sapienza University of Rome , 00161 Rome, Italy.

出版信息

J Med Chem. 2015 Dec 10;58(23):9089-107. doi: 10.1021/acs.jmedchem.5b00669. Epub 2015 Aug 7.

Abstract

Hydroxytyrosol [2-(3,4-dihydroxyphenyl)ethanol, HTyr] is a phenolic compound found in olive leaves and fruits and extra-virgin olive oil, which has well-known strong antioxidant and radical-scavenging properties. Recently, it has received particular attention for its antiproliferative and apoptotic activities and its anti-inflammatory properties. During the past few years, more efforts have been focused on synthesizing HTyr-derived compounds with enhanced biological activities for their potential use in different chronic degenerative diseases. In this paper, we report a dissertation on the current knowledge of selected synthetic HTyr derivatives and analogues and their potential use in cancer prevention and therapy, which are related to their antioxidant, antiproliferative/apoptotic, and anti-inflammatory properties. On the basis of the perspective of using HTyr-derived compounds as anticancer agents, we have taken into account only studies that were performed in experimental cell-based models.

摘要

羟基酪醇[2-(3,4-二羟基苯基)乙醇,HTyr]是一种存在于橄榄叶、果实和特级初榨橄榄油中的酚类化合物,具有众所周知的强大抗氧化和自由基清除特性。最近,它因其抗增殖和凋亡活性以及抗炎特性而受到特别关注。在过去几年中,更多的努力集中在合成具有增强生物活性的HTyr衍生化合物,以用于不同的慢性退行性疾病。在本文中,我们报告了一篇关于选定的合成HTyr衍生物和类似物的现有知识及其在癌症预防和治疗中的潜在用途的论文,这些用途与其抗氧化、抗增殖/凋亡和抗炎特性有关。基于将HTyr衍生化合物用作抗癌剂的观点,我们仅考虑了在基于实验细胞的模型中进行的研究。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验